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Changes in voltage-dependent potassium channels (Kv chan-
nels) associate to proliferation in many cell types, including
transfected HEK293 cells. In this system Kv1.5 overexpression
decreases proliferation, whereas Kv1.3 expression increases it
independently of K fluxes. To identify Kv1.3 domains involved
in a proliferation-associated signaling mechanism(s), we con-
structed chimeric Kv1.3-Kv1.5 channels and point-mutant
Kv1.3 channels, which were expressed as GFP- or cherry-fusion
proteins. We studied their trafficking and functional expres-
sion, combining immunocytochemical and electrophysiological
methods, and their impact on cell proliferation. We found that
the C terminus is necessary for Kv1.3-induced proliferation.We
distinguished two residues (Tyr-447 and Ser-459) whose muta-
tion to alanine abolished proliferation. The insertion into Kv1.5
of a sequence comprising these two residues increased prolifer-
ation rate.Moreover, Kv1.3 voltage-dependent transitions from
closed to open conformation inducedMEK-ERK1/2-dependent
Tyr-447 phosphorylation. We conclude that the mechanisms
for Kv1.3-induced proliferation involve the accessibility of key
docking sites at the C terminus. For one of these sites (Tyr-447)
we demonstrated the contribution of MEK/ERK-dependent
phosphorylation, which is regulated by voltage-induced con-
formational changes.
Voltage-gated K channels (Kv)7 comprise a large family of
channels that are expressed in both excitable and non-excitable
cells. In excitable cells they contribute to the control of resting
membrane potential (resting EM) and action potentials fre-
quency and duration. In non-excitable tissues they are involved
in processes ranging from secretion to cell proliferation (1–3)
by means of their ability to sense and modulate EM. Each Kv
channel gene encodes a single protein, and functional Kv chan-
nels consist on homo- or heterotretrameric complexes within
the same subfamilymembers (Kv1–Kv12). The large number of
Kv channel genes combined with the possibility of heterote-
tramerization creates a large functional diversity ofKv currents.
This diversity is increased by their association with accessory
proteins capable of modulating gating properties and assist
trafficking and multimerization (4). Finally, modulation of Kv
currents may also rely on posttranslational modifications such
as glycosylation and phosphorylation of the channel proteins,
which can affect their folding, their trafficking, or their func-
tional activity.
Among Kv channels, Kv1.3 was the first channel reported
to modulate cell proliferation in T cells (5). Since then, many
other Kv channels (such as Kv1.1, Kv1.5, Kv3.4, Kv10, and
Kv11.1) have been linked to migration and proliferation in
numerous non-excitable tissues, including cancer cells, T-lym-
phocytes, endothelial cells, macrophages, leukocytes, and vas-
cular smooth muscle cells (VSMCs) (1, 2, 6–9).
Kv1.3 channels have been described as modulators of cell
proliferation inmany different tissues,most notablyT-cells and
VSMCs, but also in several cancer cell types, macrophages,
microglia, and oligodendrocyte progenitors (10–12). In fact,
the pro-proliferative effect ofKv1.3 could be also reproduced by
its overexpression in a heterologous system in cells that do not
normally express the protein (13). However, although the con-
tribution of the Kv1.3 channels to activation, migration, and
proliferation seems to be well established, the mechanisms by
which Kv1.3 expression modulates these processes are mostly
unknown to date. Several mechanisms, which may not be
mutually exclusive, have been proposed, including the interac-
tion of Kv1.3 with integrin receptors (14–16), the impact of K
efflux through Kv1.3 channels on changes of resting EM needed
for cell cycle progression, or the modulation of intracellular
calcium levels that could influence the phosphorylation state of
several proliferation-related signaling processes (17, 18).
In addition to this role of Kv1.3 channels in cell proliferation,
there is evidence of a reciprocal modulation, as certain mito-
gens induce Kv1.3 channel up-regulation (5, 19, 20). In this
regard it is interesting to highlight the observed up-regulation
of Kv1.3 channels upon stimulation with PDGF, basic FGF, or
FBS and the simultaneous down-regulation of Kv1.5, another
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Kv1 subfamily member (10, 11, 13, 19, 21, 22). This observation
led us to hypothesize that theKv1.3/Kv1.5 ratio could be a land-
mark to define VSMCs phenotype, as proliferation of VSMCs
derived from different vascular beds in both mice and human
associates with an expression switch from Kv1.5 to Kv1.3 (13,
22). Furthermore, in support of this hypothesis we have previ-
ously described that heterologous expression of Kv1.3
increased HEK cell proliferation, whereas Kv1.5 expression
decreases basal HEK proliferation (13).
An important question regarding the mechanisms linking
Kv1.3 expression to proliferation is whether this association
depends on the ion-conducting properties of the channel (and
hence of the feedback regulation of EM (17) or not. There are
previous studies demonstrating that the effects of several K
channels on cell proliferation are not dependent on conducting
properties of the channel proteins (13, 23, 24). In the first study
we found that poreless Kv1.3 mutants can induce proliferation
to the same extent that wild type channels, an effect that is lost
in mutant voltage-insensitive channels or channels unable to
localize to the plasma membrane. These results suggest that
Kv1.3 proteins are docking sites that allow the activation of
proliferative signaling cascades. In nativeVSMCswe found that
PDGF-induced proliferation could be inhibited by either selec-
tive Kv1.3 blockers (Margatoxin or 5-(4-phenoxybutoxy)pso-
ralen) or by blockers of MEK/ERK and PLC pathways, both
effects being non-additive (22), which suggests a shared mech-
anism. However, the detailed description of the role of Kv1.3
channels modulating mitogen-induced signaling cascades
awaits further characterization.
In this work we sought to explore in more detail the contri-
bution of Kv1.3 channels to cell proliferation by addressing
some of the questions raised above. First, on the basis of the
opposite effects of Kv1.5 and Kv1.3 channels on HEK cell pro-
liferation, we constructed chimeric Kv1.3/Kv1.5 channels to
identify the molecular determinants involved in those effects.
Our data pointed to the intracellular C-terminal domain of
Kv1.3 as responsible for the increased proliferation rate. Next,
we explored the contribution of individual residues within this
C-terminal region bymutation to alanine of the eight predicted
phosphorylation residues. This approach identified a short
region in the C terminus (the YS segment) comprising two res-
idues (Tyr-447 and Ser-459) whose mutation abolished Kv1.3-
induced proliferation. The contribution of YS segment to
Kv1.3-induced proliferation was confirmed by designing sev-
eral mutant channels, including a C-terminal-truncated Kv1.3
channel retaining the YS segment and chimeric Kv1.5 channels
harboring the YS segment at different positions within their C
terminus. Second, we also identified one signaling pathway that
could link Kv1.3 phosphorylation and proliferation, as genetic
or pharmacological blockade of MEK/inhibited Kv1.3 induced
proliferation and phosphotyrosine labeling of the channel.
Finally, we observed that voltage-induced conformational
changes of Kv1.3 channels are important for proliferation, reg-
ulating the accessibility of these tyrosine phosphorylation sites.
Channel phosphorylation increased by maneuvers that facili-
tate the closed to open transition andwas diminished inmutant
channels that reside in the inactivated state.
Materials andMethods
HEK293 CellsMaintenance and Transfection—HEK293 cells
were maintained in DMEM medium supplemented with 5%
FBS, penicillin-streptomycin (100 units/ml each), 5g/ml Fun-
gizone, and 2 mM L-glutamine at 37 °C in a 5% CO2 humidified
atmosphere.HEK cells were transiently transfectedwith 1g of
DNA by using LipofectamineTM 2000 or TransIT-X2 reagent
(Mirrus). For siRNA experiments, HEK cells were cotrans-
fected with 1 g of DNA together with one or a mixture of
siRNA at a final concentration of 5 nM. Transfection efficiency
was quantified in each experiment by fluorescence microscopy
(35–60%). Treatments with specific inhibitors (PD98059 20
M, Tocris Bioscience) or with modified media were applied
during 4 h before determinations.
Plasmids Construction—Full-length hKv1.5 and hKv1.3 were
obtained from either cDNA or genomic uterine artery VSMC
DNA (MagNAPure Systems, Roche Applied Science) to gener-
ate C-terminal fusion proteins when subcloned into pEGFP-N1
(addgene) or pmCherry-N1 (Clontech), respectively: pEGFP-
N1-hKv1.5 and pmCherry-N1-hKv1.3. Chimeric K5N3 and
K5C3 channels were generated by PCR using Phusion Hot
Start High-Fidelity DNA Polymerase (Finnzymes). N or C ter-
mini from the Kv1.5 backbone were replaced by the corre-
sponding domains of Kv1.3, creating the fusion proteins:
pmCherry-N1-K5N3 and pEGFP-N1-K5C3. YS fragment is a
16-amino acid-residue fragment located at the proximal region
of theC-terminal of Kv1.3 and containing residues Tyr-447 and
Ser-459. The YS fragment was inserted within the hKv1.5
COOH terminus at two different positions, amino acid 532
(Kv1.5-YS532) by overlap extension PCR or at the end of the C
terminus (amino acid 613, Kv1.5-YS613), by designing overlap-
ping oligos. A truncated Kv1.3 containing the YS fragment and
lacking C-terminal amino acids 461–523 (Kv1.3-YS) was also
generated with overlapping oligos. Alanine substitutions were
introduced at any of the potential phosphorylation residues Ser,
Thr, and Tyr (predicted by NetPhos 2.0 Server) of Kv1.3 C ter-
minus.With the exception of T439A that served as a control, all
the selected residues were out of the Kv1.3-Kv1.5 consensus
amino acid sequence. Mutagenesis was performed with the
Stratagene QuikChange II site-directed mutagenesis kits using
pmCherry-N1-hKv1.3 fusion protein as template. All con-
structs were sequence-verified.
Proliferation Assays—Once transfected, cells were counted
with a hemocytometer and seeded at a density of 50,000 cells/
well on 12-mm poly-lysine-coated coverslips. Proliferation was
determined 24 h after seeding cells using a commercial kit
(ClickiT EdU Imaging Cell Proliferation Assay, Invitrogen)
following previously described protocols (22). The percentage
of cells at the S phase was quantified using 5-ethynyl-2-de-
oxyuridine (EdU) incorporation for a 30-min period. Determi-
nations were carried out in triplicate samples, and controls
were included in all experiments.
qPCR Analysis of siRNA Efficiency—HEK cells were trans-
fectedwithAmbion, Silencer Select siRNAs. The siRNAs used
were MAP2K1 (s11176 and s11168), MAP2K2 (s11170), and
negative control (AM-4611). 48 h afer transfection total RNA
was isolated using TRIzol reagent (Invitrogen), andmRNA lev-
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els were determined by qPCRwith Taqman probes in a Rotor-
Gene 3000 instrument (Corbett Research). Data were analyzed
with the threshold cycle relative quantificationmethod (Ct),
normalized to an endogenous control (ribosomal protein L18).
Taqman assays used were Hs00983247_g1 (MAP2K1) and
Hs01673993_m1 (MAP2K2). The corresponding siRNAs
reducedMAP2K1mRNA by 10-fold (from 0.96 0.08 to 0.1
0.003) and MAP2K2 by 3-fold (from 1.05 0.1 to 0.36 0.6).
No cross-reactivity was observed.
Apoptosis Assays—Apoptosis was detected by TUNEL
method (In Situ Cell Death Detection kit, Roche Applied Sci-
ence) 24 h after seeding transfected HEK293 cells. Experimen-
tal positive and negative controls were also performed.
Electrophysiological Studies—Ionic currents were recorded
at room temperature using the whole-cell or the cell-attached
configuration of the patch clamp technique as previously
described (13, 19). For the whole cell experiments we used an
internal solution (High-Ki) containing (125 mM KCl, 4 mM
MgCl2, 10 mM HEPES, 10 mM EGTA, 5 mM MgATP (pH 7.2
withKOH)). The composition of the bath solution (Standard-e)
was 141mMNaCl, 4.7mMKCl, 1.2mMMgCl2, 1.8mMCaCl2, 10
mM glucose, and 10 mM HEPES (pH 7.4 with NaOH). Whole-
cell currents were recorded using anAxopatch 200 patch clamp
amplifier, filtered at 2 kHz (3 db, 4-pole Bessel filter) and
sampled at 10 kHz. When leak subtraction was performed, an
online P/4 protocol was used. Recordings were digitized with a
Digidata 1200 A/D interface driven by CLAMPEX 8 software
(Axon Instruments). Outward K currents were elicited by
depolarizing pulses from a holding potential of80mV to40
mV applied in 10-s intervals. In some cells full current/voltage
curves were constructed from potentials ranging from 60 to
100mV in 10-mV steps. Kv1.3 and Kv1.5 were defined by
their sensitivity to the selective blockers 5-(4-phenoxybu-
toxy)psoralen (100 nM) and diphenyl phosphine oxide-1 (DPO;
1 M), respectively.
Cell attached recordings were used for the kinetic character-
ization of the currents, with a pipette solution containing 120
mM NaCl, 30 mM KCl, 2 mM CaCl2, and 10 mM HEPES (pH 7.4
with NaOH) and a bath solution (High-Ke) with 150 mM KCl,
0.5mMMgCl2, 10mMHEPES, 1mM EGTA (pH 7.2 with KOH).
Currents were elicited by 500 ms depolarizing pulses to 40
mV from a holding potential of 80 mV. IV curves were con-
structed with 800-ms-depolarizing pulses from 80 to 100
mV in 20-mV steps applied every 10 s. Conductance curves
were obtained from the amplitude of the fit to a mono-expo-
nential function of the tail currents upon repolarization to80
mV. After normalization to the maximal conductance (Gmax)
the data were fitted to a Boltzmann function to obtain the V0.5
of activation and the slope of the curve. The steady-state inac-
tivation was studied with a two-pulse protocol, in which a
200-ms pulse to40 mV was preceded by a family 1.8-s depo-
larizing pulses from 100 to 40 mV in 20-mV intervals
applied every 20 s. The peak current amplitude of the40-mV
pulse was normalized to themaximal amplitude (obtained with
the 100-mV prepulse), plotted as a function of the prepulse
potential, and fitted to a Boltzmann function. To determine the
membrane potential in the cell-attached patch, we assumed
that in the High-Ke there was no voltage difference across the
cell membrane. This was confirmed with the measurement of
the Ki from an instantaneous IV curve. 100-ms depolarizing
prepulses to60mVwere followed by repolarization to poten-
tials from 100 to 60 mV. The IV curve obtained allowed
determination of the reversal potential of the current and cal-
culation of theKi so that we could correct the estimated trans-
membrane potentials.
Immunocytochemistry—Transfected HEK293 cells were
fixed with 3.7% paraformaldehyde 24 h after seeding and
blocked in 2% of normal goat serum with PBS (nonpermeabi-
lized cells) or Triton X-100 0.1% (permeabilized cells). Non-
permeabilized cells were incubated with anti-Kv1.3 or anti
Kv1.5 extracellular primary antibodies (APC101 or APC150,
Alomone Labs), whereas permeabilized cells were incubated
with anti-Kv1.3 COOH (75-009, NeuroMab) or anti-Kv1.5
COOH (APC004, Alomone Labs), all at a final concentration of
1:50. Goat anti-rabbit 488 (A-11008, Molecular Probes), goat
anti-rabbit 532 (A-11009, Molecular Probes), or goat anti-
mouse 532 (A-11002, Molecular Probes) secondary antibodies
were used at 1:1000. Hoechst 33342 (1:2000)-labeled nuclei and
coverslips were mounted with Vectashield (Vector Laborato-
ries). Photomicrographs were acquired with a LEICA SP5 con-
focal microscope using LAS software.
Image Analysis—Confocal images from non-permeabilized
transfected HEK293 cells were used to assess the relative
expression of Kv1.3 and Kv1.5 constructs at the plasma mem-
brane. 63 (1.4NA) objectives were used to capture images and
Z-stackswith a pinhole aperture of 1 airy unit (95.5mwith our
experimental settings) and a voxel size compatible with the
Nyquist criterion. Images were binarized using a threshold that
was automatically defined by Fiji software rsb.info.nih.gov).
EGFP (488ex/507em) or mCherry fluorescence (587ex/610em)
was taken as ameasure of total expression of the fusion proteins
(ATotal), whereas secondary antibody images, 532 (531ex/554em)
or 488 (495ex/519em) defined the membrane area (AMembrane).
Both values were used to compute the % of membrane
expression.
Immunoprecipitation—Transfected HEK293 cells incubated
with the corresponding treatments were treated with 250 M
pervanadate during the last 5 min of incubation. Cell lysates
collected in radioimmune precipitation assay buffer (150 mM
NaCl, 50mMTris (pH 8), 1%Nonidet P-40, 0.2% sodiumdeoxy-
cholate) with 1 protease inhibitor mixture (Roche Applied
Science) and 1 mM phosphatase inhibitors NaF and Na3VO4
were incubatedwithRFP/GFP-Trap_Abeads (ChromoTek) for
2–3 h and used for immunoblotting. They were separated by
SDS-PAGE in 10% polyacrylamide gels and transferred to
nitrocellulose membranes. Mouse monoclonal anti-phospho-
tyrosine antibody (clone 4G10,Millipore), ratmonoclonal anti-
RFP antibody (5F8, ChromoTek), rat monoclonal anti-GFP
(3H9, ChromoTek), rabbit anti p-ERK1/2 (Cell Signaling 9101),
and mouse monoclonal anti--actin (ab8226, Abcam) were
used at a final concentration of 1:1,000 and incubated overnight
at 4 °C. Secondary antibodies HRP-goat anti-mouse (Dako)
HRP-goat anti-rat (Abcam), or HRP-goat anti-rabbit (Santa
Cruz, sc-2301) were used at final concentration 1:20,000 for 1 h
and developed with VersaDoc 4000 Image System (Bio-Rad)
using chemiluminescence reagents (SuperSignal West Femto
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Chemiluminescent Substrate, Pierce). The relative amount of
protein was calculated by densitometric analysis of the bands
using Fiji (Image J) software.
Data Analysis—Electrophysiological analyses were per-
formed with both the CLAMPFIT subroutine of the PCLAMP
software (Axon) and ORIGIN 7.5 software. Pooled data are
expressed as the means S.E.
The composite data are expressed as the means  S.E. Sta-
tistical analysis was performed using paired or unpaired test as
appropriate. For pairwise comparison of normal distribution,
Student’s t test was used. For comparisons of several groups,
one-way ANOVA was performed followed by a Shapiro-Wilk
normality test of the fit of the residuals. In the case of normal
distributions, comparisons among groupswere performedwith
Tukey’s honest significant difference (HSD) test. In the case of
un-normal distributions (i.e. p value in the Shapiro-Wilk test of
residuals0.05), a Kruskal-Wallis one-way analysis of variance
by ranks was used as a nonparametric method to test whether
samples originate from the same distribution. When the null
hypothesis was rejected, a pairwise Mann-Whitney-Wilcoxon
(MWW) test with a Bonferroni correction was applied. In all
cases, differences were considered to be significant when p 
0.05.
Results
The C-terminal Domain Contains the Molecular Determi-
nants of Kv1.3-induced Proliferation—Weconstructed two chi-
meric channels (K5N3 and K5C3) using the backbone of Kv1.5
channels and substituting either the amino (K5N3) or the
C-terminal (K5C3) intracellular domains with the correspond-
ing regions of Kv1.3 channels. Both chimeras were constructed
as fusion proteins with a fluorescent protein attached to the C
terminus: EGFP for K5C3 and Cherry for K5N3. Upon expres-
sion, both chimeras formed functional channels with some
mixed biophysical properties (Fig. 1A and Table 1); 1) current
density was much larger for the K5C3 than for K5N3 channels;
2) inactivation time course andV0.5 of activationwere similar to
Kv1.5 channels in both chimeras, and 3) V0.5 of inactivation of
K5N3 was similar to Kv1.3, whereas K5C3 was not different
from Kv1.5. Differences in current density were related to the
efficiency of trafficking to the plasma membrane as shown by
FIGURE 1. Functional expression of K5N3 and K5C3 chimeras. A, representative traces of K5N3 and K5C3 currents evoked by a steady-state inactivation
protocol in transfected cells. A family of 1.8-s depolarizing pulses from60 to40mV (as indicated in the y axis) was followed by a 200-ms depolarizing pulse
to40. The peak current amplitude in the prepulse was used to construct activation curves, whereas the amplitude of the pulse at40 mV was plotted as a
function of the voltage of the prepulse to create the inactivation curves. The trace elicited by the voltage closest to the inactivation V0.5 is depicted in red. The
lower panel shows average, normalized conductance-voltage relationships and Boltzmann fits for activation and inactivation obtained from Kv1.3-, Kv1.5-,
K5C3-, and K5N3-transfected cells. Data are represented as themean S.E. of 7–11 cells. B, confocal images obtained in HEK293 cells transfectedwith vectors
expressing K5C3-EGFP and K5N3-Cherry chimeric vectors. The left panels show the fluorescence of the fusion protein, the middle panels show the antibody
labeling, and the right panels showthemerged imageswithHoechst to seenuclear staining (blue).Membraneexpressionwasdetermined innonpermeabilized
cells with an extracellular anti-Kv1.5 antibody (shown in red for K5C3 and in green for K5N3). Subcellular expression was determined in permeabilized cells by
using antibodies against the cytoplasmic C terminus (CT), an anti-Kv1.3-CT antibody (red) and an anti-Kv1.5-CT antibody (green), respectively. Constructs are
depicted on the left schemes.
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immunocytochemical labeling of non-permeabilized cells with
extracellular Kv1.5 antibody (Fig. 1B and Table 2). The fluores-
cence overlapping signals of the labeled antibody and the fusion
proteins demonstrates that most K5C3 molecules localized to
the cell surface, whereas a large amount of K5N3 was retained
intracellularly and did not reach the plasma membrane.
The pharmacological profile of both chimeras resembles that
of Kv1.5 channels (Fig. 2). Both mutants were sensitive to the
Kv1.5-selective blocker DPO and did not respond to the selec-
tive Kv1.3 blocker 5-(4-phenoxybutoxy)psoralen (100 nM, data
not shown).We tested proliferation after transient transfection
ofK5N3-, K5C3-, Kv1.3-, Kv1.5-, or EGFP-expressing plasmids.
We observed that K5N3 inhibited proliferation to the same
extent as Kv1.5, whereas K5C3 potentiated proliferation very
much like Kv1.3 (Fig. 3A). These experiments suggest that the
molecular determinants for the effect of the channels on cell
proliferation are contained in their C-terminal domain. How-
ever, the reduced membrane expression (and hence the small
current density) of K5N3 could be a potential caveat for our
interpretation, as the low expression levels (and not the molec-
ular structure of the chimera) could be altering proliferation.
To test this possibility, HEK cells were co-transfected with
K5N3 and an excess of Kv2.1 subunit, a chaperone subunit of
Kv1 channels. This maneuver significantly increased the sur-
face expression of the chimeric channels and, as previously
described for both Kv1.5 and Kv1.3 (25, 26), induced a hyper-
polarizing shift on the activation curve (Fig. 3B). However,
despite the increased current density there were no significant
changes on the effect on HEK cells proliferation (Fig. 3C).
Role of Individual Sites within the C-terminal Domain of
Kv1.3 to the Proliferation Rate of HEK Cells—Our data suggest
that the C-terminal domain of Kv1.3 channels was responsible
for the channel effect on proliferation. To identify more pre-
cisely the amino acid residues involved in this effect, we
mapped the phosphorylation sites within this region by gener-
ating eight mutants in which individual serines, tyrosines, or
threonines were replaced by alanine (Fig. 4). Compared with
wild typeKv1.3 channelswe did not observe significant changes
in any mutant in either their functional expression (studied
with electrophysiological techniques) or their membrane traf-
ficking (determined as above using an extracellular Kv1.3 anti-
body; Tables 1 and 2). Proliferation studies were carried out
with the eight mutants always using Kv1.3 and cherry transfec-
tions as positive and negative controls, respectively. Our data
(Fig. 4) shows that five of the point mutants (Y447A, S459A,
S473A, S475A, Y477A) altered the pro-proliferative effect of
Kv1.3 channel expression. Interestingly, three of them
(Y447A, S459A, and Y477A) completely abolish the effect, as
the proliferation in the presence of any of them was no dif-
ferent from control, cherry-transfected cells. Evaluation of
the current density obtained with these transfectants (Fig. 4)
showed no difference with the wild type Kv1.3 channels in all
the mutants explored, in agreement with the co-localization
studies (Table 2).
Confirmation of the Pivotal Role of Tyr-447 and Ser-459 Res-
idues in Kv1.3-induced Proliferation—Modulation of Kv1.3
channel activity and kinetics in response to treatment with EGF
or insulin has been shown to involve phosphorylation of tyro-
sine 477 but not of 447 (27). However, in our study point muta-
tions to alanine of residues Tyr-447 and Ser-459 generated the
two channel mutants that more efficiently abolished Kv1.3-in-
duced proliferation. These residues are located at the proximal
end of the Kv1.3 channel C terminus, in a region not previously
identified as a conserved motif for interaction with growth fac-
TABLE 1
Electrophysiological characterizationof theamplitudeandkineticsof thecurrents recorded fromKv1.3andKv1.5 channels and themutantsand
chimeras
All data were obtained from cell-attached experiments. Data are the mean S.E. (n). Statistics were performed against the corresponding wild type channel (Kv1.3 for the
four upper rows or Kv1.5 for the lower rows), and significant differences are depicted in bold. Pairwise comparison, t test.
Channel
Peak current
40 mV
Inactivation
at 800 ms
Activation Inactivation
V0.5 Slope V0.5 Slope
pA % mV mV
Kv1.3 1501.88 207.3 (10) 70.8 2.3 (10) 46.9 2.8 (8) 6.2 1 (8) 46.6 1.7 (6) 5 0.5 (6)
Kv1.3-Y447A 1618.6 283.4 (5) 62.1 2.8 (5) 50.2 2.3 (5) 7 2.7 (5) 48.7 1.8 (5) 3.6 0.9 (5)
Kv1.3-S459A 2325.2 709.4 (5) 79.3 3.4 (5) 41.3 4.2 (5) 4.7 1 (5) 48.9 7.8 (5) 3.3 0.5 (5)
Kv1.3-YS 508.5 139.2a (9) 75.8 4.1 (9) 55.3 2.8b (8) 3.3 0.6b (8) 44.2 2.6 (6) 3.9 0.7 (6)
K5C3 1077.1 288.2 (13) 38.9 4.3 (13) 20.4 1.9 (11) 10.6 1 (11) 31 2.2 (6) 5.3 0.9 (6)
K5N3 41.3 6.1b (7) 35 3 (7) 25.9 1.5 (7) 5.3 1 (7) 41.7 1.4a (6) 4.3 0.8 (6)
K5N3Kv2 170.7 37.6 (8) 40.7 4.2 (8) 39.6 1.2a (6) 6.6 1.3 (6) 45.5 1.2c (7) 6.2 1.3 (7)
Kv1.5-YS532 241.6 61.4 (8) 30.9 3.7 (8) 14.8 3.7a (8) 13.9 1.5a (8) 25.1 1.9 (5) 6.2 0.7 (5)
Kv1.5-YS613 252.6 81.6 (10) 29.6 5 (9) 22.2 2.3 (10) 10.7 1.4 (10) 30.2 4.8 (7) 5.9 1.3 (7)
Kv1.5 577.3 234 (7) 37.7 2.6 (6) 27.7 1.6 (7) 7.2 0.8 (7) 26.5 3.1 (6) 6.8 1.9 (6)
a p 0.01.
b p 0.05
c p 0.001.
TABLE 2
Summary data of the surface expression of all Kv1.3 and Kv1.5
constructs
Data are themean S.E. (n). Statistical differenceswith the correspondingwild type
channel (Kv1.3 for the Kv1.3 constructs and Kv1.5 for Kv1.5 constructs) are indi-
cated. For Kv1.3 constructs significant differences were obtained with one-way
ANOVA followed by Tukey’s HSD. For Kv1.5 channels, a nonparametric Kruskal-
Wallis one-way ANOVA was used followed by a pairwise MWW test with Bonfer-
roni correction. Significant differences are depicted in bold.
Kv1.3
constructs
% Cell surface
expression Kv1.5 constructs
% Cell surface
expression
Kv1.3 39.82 2.28 (23) Kv1.5 37.72 1.97 (40)
Kv1.3- T439A 43.31 2.37 (11) K5C3 96.11 4.01a (10)
Kv1.3 Y447A 36.80 4.78 (13) K5N3 21.11 1.6b (25)
Kv1.3-S459A 42.11 4.81 (13) K5N3 Kv2 27.32 2.83c (20)
Kv1.3-S470A 47.39 3.26 (12) Kv1.5-YS532 44.75 5.6 (18)
Kv1.3-S473A 46.51 3.25 (11) Kv1.5-YS613 40.58 4.4 (15)
Kv1.3-S475A 42.95 4.31 (12)
Kv1.3 Y477A 34.14 2.55 (11)
Kv1.3-T493A 39.97 1.76 (22)
Kv1.3-YS 30.31 3.3c (15)
a p 0.001.
b p 0.01
c p 0.05.
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tor-associated kinases.We constructed some additional chime-
ric channels to confirm the contribution of this region (that we
named the YS segment; Fig. 4) to the effect of Kv1.3 channels on
proliferation. We created a truncated Kv1.3 channel with a
short C-terminal domain comprising only the YS segment
(Kv1.3-YS). Two additional chimeric channels were con-
structed by inserting this YS segment at two different positions
into the Kv1.5 channel C terminus: either proximal in the
equivalent location in Kv1.3 channels (after residue 532, Kv1.5-
YS532) or at the end of the protein (Kv1.5-YS613). Both Kv1.5-
FIGURE2.Dose-responsecurves for theeffectofDPOonK5N3andK5C3currents.A, theplots showthecurrent amplitudeat theendofdepolarizingpulses
to40 mV from a holding potential of80 mV, applied every 10 s, from a HEK cell transfected with K5N3 (upper graph) or with K5C3 (lower graph). DPO was
applied to the bath solution at the concentrations indicated (in M) during the time marked. The insets show sample current traces at the different DPO
concentrations. B, normalized dose-response curves obtained for the inhibitory effect of DPO on the current amplitude in both chimeric channels as well as in
Kv1.5 (open circles). Each data point is the mean S.E. of 9–18 cells. The lines show the fit of the data from K5N3 and K5C3 channels to a Hill function (IC50	
0.66 M for K5C3 and 0.26 M for K5N3).
FIGURE 3. Effects of K5N3 and K5C3 channels on HEK cell proliferation. A, proliferation rate of HEK cell transfected with GFP-expressing vector (used as
control) or with the indicated channels was determined bymeasuring the fraction of cells incorporating EdU reagent after 30min of incubation inmedia with
5% FBS. Each bar is themean S.E. n	 12–15. Data were from at least four different experiments. Comparisons were carried out with a one-way ANOVA and
Tukey’s HSD test as post hoc analysis, and significant differences with control and GFP-transfected cells are shown. *, p 0.05; **, p 0.01. B, representative
examples of family of currents elicited by 500-ms depolarizing pulses from80 to60 mV in 20 mV from a HEK cell expressing K5N3 alone or together with
the chaperone subunit Kv2.1. In addition to the increased current amplitude, therewas a leftward shift in the voltage dependence of activation upon Kv2.1
coexpression. The data are representative of seven cells in each group. C, the changes in the current density of K5N3 channels do not modify their effect on
proliferation. Theplot shows the inhibitionofproliferation (left bars;n	4) and the currentdensity at40mV (right plot;n	8–15) fromwhole cell experiments
of HEK293 expressing Kv1.5, K5N3, and K5N3Kv2.1. Statistical differences from control (Kv1.5) were calculated with a Kruskal-Wallis test followed by a
pairwise MWWwith Bonferroni correction. pF, picofarads.
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YS532 andKv1.5-YS613 showkinetic and pharmacological prop-
erties similar to Kv1.5 channels. Moreover, their trafficking did
not show significant differences comparedwithwild type chan-
nels (Fig. 5B, Table 2). Meanwhile, Kv1.3-YS showed biophysi-
cal properties similar to Kv1.3 channels (Fig. 5A), albeit we
observed some differences in their activation kinetics (Table 1)
as well as a decreased membrane expression (Table 1 and 2).
The impact on proliferation of these constructs is summarized
in Fig. 5C. The truncated Kv1.3 channel (Kv1.3-YS) was still
able to induce proliferation, although to a lesser degree than
wild type Kv1.3. Interestingly, the Kv1.5-YS532 chimera
increased proliferation similar to Kv1.3, whereas Kv1.5-YS613
behaved as Kv1.5 channels. These data indicated that the YS
segment suffices to convert Kv1.5 channels into Kv1.3 channels
with regard to their proliferative properties, but the environ-
ment in which the YS segment is inserted is relevant for this
effect. In fact, all the chimeras containing the Kv1.3 YS segment
located in the homologous region of Kv1.5 channels (the prox-
imal end of C termini), have a stimulating effect on HEK prolif-
eration (Fig. 5D) that is independent of the amount of current
they can carry (or their membrane expression).
Identification of the Proliferation-activated Signaling Path-
way Modulated by Kv1.3 Expression—The pro-proliferative
role of native Kv1.3 channels in VSMCs is mediated by ERK1/2
signaling pathway, as selective blockers of Kv1.3 or selective
blockers of the ERK1/2 cascade inhibited proliferation in a non-
additive fashion (22). We have explored if this pathway could
also be involved in theKv1.3 induced proliferation inHEK cells.
Treatment of HEK cells with the ERK1/2 blocker PD98059 (20
M) was able to suppress Kv1.3-induced proliferation and had
no effect in control cells (Cherry-transfected) or in cells trans-
fected with the mutant channels Y447A and S459A (Fig. 6A).
Genetic blockade of MEK1/2 by co-transfection of cherry or
Kv1.3 constructs with a mixture of three MEK1/2 siRNAs fully
reproduced the effects of PD98059 on HEK cells proliferation
(Fig. 6B). These experiments suggest that the Kv1.3 effect on
proliferation requires ERK1/2, and we hypothesize that either
Tyr-447 or Ser-459 needs to be phosphorylated for Kv1.3 chan-
nels to induce proliferation. Immunoblots with anti-phospho-
tyrosine antibodies of Kv1.3 or Y447A-transfected HEK lysates
after immunoprecipitation with anti-Cherry antibody support
this hypothesis. InKv1.3-transfected cellswe showa clear phos-
phorylation signal of Kv1.3 that decreased after PD98059 treat-
ment. There was a decreased basal phosphotyrosine content of
Y447A-transfected cells compared with Kv1.3, and the treat-
ment with the inhibitor did not have any effect (Fig. 6C).
Besides, immunoprecipitation assays with anti-Cherry anti-
bodies of Cherry- or Kv1.3-cherry-transfected cells demon-
strated binding of pERK to the complexes containing Kv1.3
channels only upon treatment with phosphatase inhibitors,
suggesting a brief, reversible interaction between them (Fig.
6D).
The correct location ofTyr-447 and Ser-459within the chan-
nel protein seems to also be relevant for the effect on prolifer-
FIGURE 4.Characterization of the effects on proliferation of Kv1.3 COOH terminus pointmutants. The schematic shows the position in the C terminus of
Kv1.3 of the phosphorylatable residues (in red) that have been mutated to alanine. Also, AMP kinase and the insulin receptor kinase putative motifs are
indicated as well as the YS segment. Conserved residues in the C terminus of Kv1.3 are underlined. The upper panel shows EdU incorporation assay of HEK293
cells transfected with each point mutant channels using Cherry and Kv1.3 expressing cells as controls. Each bar is the mean S.E. (n	 6–20 determinations
from 3–7 different experiments). *, p 0.05 comparedwith Kv1.3; #, p 0.05 comparedwith Cherry, pairwiseMWWwith Bonferroni correction. The lower plot
shows the current density at40 mV obtained from whole-cell experiments (n	 5–8 cells).
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ation (as illustrated with the differences between Kv1.5-YS532
and Kv1.5-YS613). This could be attributed to conformational
changes of the channel that expose these residues. Based on our
previous data (13) we hypothesize that conformational changes
in response to changes in EM may be necessary to expose the
identified phosphorylation sites in the YS segment. We were
able to explore this hypothesis for the tyrosine residues by
studying the effect of high K-induced depolarizations. Kv1.3-
transfected cells were incubated with extracellular solutions
containing 10, 20, and 60 mM Ke during 20 min. High Ke
induced a significant increase of phosphotyrosine labeling of
Kv1.3 channels at all the concentrations tested (Fig. 7A). The
effect of depolarization on tyrosine phosphorylation was tran-
sient, returning to control values for incubations of 2–4 h in
high Ke (Fig. 7B). In addition we found that the phosphoty-
rosine content is higher in Kv1.3WF channels, a poreless chan-
nel mutant, and decreased in the pore and gate double mutant
Kv1.3 WF3x, which does not have voltage-gating transitions at
resting EM or in the Kv1.3 AYAmutant, a poreless channel that
does not traffic to the plasma membrane (Fig. 7C). Strikingly,
Kv1.3 WF3x and Kv1.3 AYA were not able to induce HEK cell
proliferation, whereas Kv1.3WF had an effect similar to Kv1.3
channels (13).
Discussion
In this study we undertook the molecular dissection of the
Kv1.3 channel and the parallel changes observed in HEK pro-
liferation to conclude with an attractive hypothesis aimed to
understand the role of ion channels in cell proliferation. The
opposite effect on cell proliferation of two channels of the same
subfamily (Kv1.3 andKv1.5) has been of seminal importance for
accomplishing our goals. This antithetical role has been
described in different cell lineages, includingVSMCs, oligoden-
drocyte progenitor cells, and microglia (10–13, 21). The fact
that these antagonist effects on cell proliferation could still be
observed upon heterologous expression of the channels repre-
sented an opportunity to explore the molecular mechanisms
that associate the expression of these channelswith the changes
in the rate of proliferation. The data obtained from our analysis
provided clear-cut results regarding the mechanisms by which
Kv1.3 channel expression can facilitate cell proliferation.
All the chimeric and mutant channels were located at the
plasma membrane. Two of them had a decreased functional
expression (i.e. a decreased current density) compared with
their corresponding wild type channels, namely Kv1.3-YS
(comparedwithKv1.3) andK5N3 (comparedwithKv1.5). It has
been reported that Kv1.3 channels harbor a di-acidic signal
FIGURE 5.Characterizationof theKv1.3 andKv1.5mutant channels containing theYS segment.A, average normalized activation and inactivation curves
are shown as conductance-voltage relationships for Kv1.3, Kv1.5, the truncated Kv1.3-YS channel, and the chimeras Kv1.5-YS532 and Kv1.5-YS613. All datasets
were fitted to Boltzmann functions. Each data point is themean S.E. of 6–11 cells. B, confocal images of non-permeabilized cells transfected with Kv1.3-YS-
Cherry, Kv1.5-YS532-EGFP, and Kv1.5-YS613-EGFP. An extracellular anti-Kv1.3 antibody was used to label Kv1.3-YS (green), whereas the extracellular anti-Kv1.5
antibody was used for Kv1.5-YS532 and Kv1.5-YS613 chimeras (red). Nuclei were stained by Hoechst (blue). C, proliferation rate of the indicated channels or
GFP-transfected cells (control) was determined by measuring EdU incorporation. Significant differences when comparing to Kv1.3 (*) or to control (#) are
indicated. Statistical analysis was performed with one-way ANOVA followed by a Tukey’s HSDmultiple comparison. Each bar is the average of 9–15 determi-
nations from5different assays.D, the averagepeak current amplitude obtained in cell-attached experiments for Kv1.5 channels and all the Kv1.5 chimeraswas
plotted against the % of the channels expressed at the plasma membrane (upper graph) or their normalized effect on proliferation (taking 100% as the
proliferation rate of GFP-transfected HEK cells, lower graph). The correlation between expression and current was fit to a linear regression curve (y	 18.54
0.0066x, R2	 0.85, p	 0.008), but there was no correlation between proliferation and current amplitude (R2	 0.23, p	 0.19).
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(residues Glu-481/482 in human) essential for anterograde
transport and surface expression (28) that is not conserved in
Kv1.5 channels (see the schematic in Fig. 4). This could contrib-
ute to the decreased membrane expression of Kv1.3-YS and to
the large increment both in current amplitude and membrane
expression of K5C3 (see Tables 1 and 2). In this line, the
reduced expression with K5N3 suggest that either the Kv1.3 N
terminus has unique ER retention or retrograde trafficking sig-
nals or that theKv1.5N terminus has forward trafficking signals
that are not present in Kv1.3.
Also, the changes in the biophysical properties of ourmutant
or chimeric constructs were in good agreement with the exist-
ing data regarding their molecular determinants. We confirm
that the cytoplasmic N-terminal domains of Kv1.3 and Kv1.5
determine the voltage-dependent inactivation properties of the
channels (29), and we reproduce the kinetic changes upon
Kv2.1 coexpression (25, 26). Finally, the changes in the voltage
dependence of activation observed in Kv1.3-YS and Kv1.5-
YS532 are consistent with previous observations indicating that
the coupling of the voltage sensor movement to operation of
the gate mainly involves physical interactions of the S4-S5
linker with the intracellular end of S6 and/or the cytoplasmic
“C-linker” region (30).
The contribution of Kv channels to cell proliferation has
been associatedwith severalmechanisms that do not need to be
mutually exclusive such as their ability to sense and regulate
EM, their role in the control of cell volume, or their contribution
to the regulation of calcium fluxes and intracellular calcium
concentrations by means of the hyperpolarization of the EM.
Most of these mechanisms rely on the potassium gradients and
focus on the potassium fluxes that generate the changes in cell
volume or in resting EM and do not consider the contribution of
the ion channel molecule itself. However, non-conducting sig-
naling roles of ion channels can also accompany these effects
and in some cases are themain signal to induce proliferation. In
these cases the cell cycle-associated oscillations of resting EM
may bemere byproducts of the changes in the expression or the
conformational states of the ion channel (31). There are very
few studies dissecting the contribution to the cell cycle of both
conducting and non-conducting properties of ion channels, as
this requires the use of genetic or pharmacological tools to
selectively abolish ion permeation, although these evidences
are clear for a few Kv channel molecules in different systems
(32). Even more scarce is the information regarding the link(s)
between voltage-dependent gating of Kv channels and cell cycle
progression, although some clues are provided by the charac-
FIGURE 6.MEK/ERK signaling pathway is involved in Kv1.3-induced proliferation. A, proliferation rate of HEK293 cells transfected with an empty vector
(Cherry), Kv1.3 channel, and the Y447A and S459A Kv1.3 mutant channels. Cells were kept in control media alone (white bars) or preincubated with PD98059
(20 M) 4 h before the EdU incorporation assay. Data are the mean S.E. n	 5–10 determinations. ***, p 0.001 when compared with its corresponding
control (untreated), pairwise comparison with student t test. B, proliferation rate of HEK cells transfected with Cherry or Kv1.3 constructs alone (Control) or
together with negative control siRNA or a mixture of 3 MEK1/2 siRNAs. The effect of PD98059 treatment in this latter group was also studied. Data are the
meanS.E. of 5–12determinations fromat least three independent experiments. Student’s t testwasused to comparebetweenCherry- andKv1.3-transfected
cells in each group. C, the bar plots show the densitometric analysis obtained from 4–6 different experiments in which samples were immunoprecipitated (IP)
with RFP-Trap_A beads and incubated with anti-phosphotyrosine (P-Tyr) antibody. The data were corrected for the labeling obtained with anti-cherry anti-
bodies and normalized to the amount obtained for untreated Kv1.3-transfected cells. Pairwise Student’s t test was used to compare between control and
treated cells for each condition (Kv1.3 and Y447A). A representative immunoblot for Kv1.3- and Y447A-transfected cells incubated with () or without ()
PD9805920M is shown (the target proteinbandswere
84 kDa). D, representative immunoblot of cell lysates fromCherry (Ch)- or Kv1.3-transfectedHEK cells
with anti pERK1/2 antibody with or without treatment with phosphatase (P.) inhibitors. -Acting was used as loading control. The lower blot shows anti-
pERK1/2 labeling after immunoprecipitation of the same lysates with RFP-Trap.
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terization of the proteins associated with Kv channels in the
macromolecular complexes (33, 34). In the case of Kv1.3 chan-
nels, these proteins include growth factor receptors (35) and
cytoskeleton-associated molecules (15, 36). However, the
interactions within these macromolecular complexes or the
relationship between ion fluxes through the channels and
the signaling cascades leading to proliferation awaits further
characterization.
Our previous work with Kv1.3 mutant channels lacking
either the pore or the voltage-gatingmechanisms indicated that
the ability of Kv1.3 channels to sense the voltage was essential
for its role in facilitating proliferation, as only poreless channels
with normal gating behaviorwere as effective aswild typeKv1.3
channels.We speculate that changes in resting EM that contrib-
ute to cell cycle progression could be sensed and transduced
through Kv1.3 channels. The requirement of Kv1.3 channels
(and not a closely related Kv1 subfamilymember such as Kv1.5)
for the potentiation of proliferation indicates that either the
Kv1.3 channel itself or other closely associated molecules must
be targets/effectors in the proliferation signaling pathway. We
postulated the existence of specific docking sites within the
channel molecule whose exposure to proliferative stimulus is
regulated by voltage-dependent conformational changes and
potentiate cell proliferation. The results presentedhere support
this hypothesis, providing some additional information regard-
ing the molecular identification of these docking sites, the
nature of the interacting molecules, and the mechanisms
involved. We found that Kv1.3-induced proliferation of HEK
cells can be fully abolished by three point mutations that elim-
inate three phosphorylation sites at the C-terminal domain.
Moreover, we demonstrate that at least for one of these residues
(Tyr-447) potentiation of proliferation is mediated by its phos-
phorylation and is dependent of an intact MEK/ERK signaling
pathway (Fig. 6, A and C). Finally, our results with the chimeric
channels containing theYS segment suggest that the location of
this domain within the channel molecule also determines its
ability to enhance proliferation.We speculate that the exposure
of this region for being phosphorylated requires a conforma-
tional change of the molecule; differences in phosphotyrosine
labeling of Kv1.3 channels in the presence of high Ke suggests
that voltage-dependent transitions from closed to open state
could represent this conformational change. Resting EM of
HEK cells changes from a mean value of 15 mV in mock-
transfected (or Kv1.3WF-transfected) cells to 43 mV in
Kv1.3-transfected cells (13). Interestingly, phosphorylation of
Kv1.3WF is significantly higher than Kv1.3, as expected if we
take into account that Kv1.3WF-transfected cells are more
depolarized. Increasing Ke from 5.4 to 10, 20, or 60 mM depo-
larizes the cells to EM valuesV0.5 of activation of the channel
(38,30, and14 mV, respectively), and in agreement with
that we found increased Kv1.3 phosphorylation in the three
conditions. Also, the requirement of a closed to open transition
can explain the increased Tyr phosphorylation of Kv1.3WF
(that shows normal gating currents) and the absence of Tyr
phosphorylation of the pore and gating double mutant
Kv1.3WF-3x (13). The contribution of phosphorylation of
FIGURE 7. Phosphotyrosine labeling of Kv1.3 channels is modulated by voltage-dependent transitions. A, representative immunoblots and summary
data fromKv1.3-transfected cells incubatedwith the indicatedKe solutions for 20minbefore RFP-Trap immunoprecipitation (IP). p-Tyr labelingwas corrected
for anti-Cherry labeling and normalized to control data (cells incubated in 5.4 mM K). Statistical differences from control condition were established with a
Tukey’s HSD comparison after one-way ANOVA. B, time course of the effect of incubations with 60 mM Ke. At each time point, p-Tyr labeling is shown as the
ratio of the 60/5.4 mM Ke signal. Each data point is the mean  S.E. of 5–12 determinations from at least three independent experiments. Statistics were
obtainedwith aMWW test pairwise comparison with Bonferroni correction and comparedwith the p-Tyr ratio at t	 5min. C, immunoblot and densitometric
average values ofGFP-Trap-immunoprecipitated cells transfectedwithKv1.3 orW389F-,WF3x-, andAYAKv1.3-mutant channels. Data arenormalized as above
and are represented as the mean  S.E. of 3–5 different experiments. Significant differences with Kv1.3 wild type channels were estimated with pairwise
Student’s t tests. *, p 0.05; **, p 0.01; ***, p 0.001.
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Kv1.3 serine residues could not be determined with a similar
approach. Unlike phosphotyrosines, which have a very specific
epitope, there are not single antibodies that will recognize all or
most phosphoserines independently of the surrounding amino
acid sequence, and we failed to show phosphoserine labeling of
Kv1.3 using several different experimental procedures. How-
ever, the physical association of pERK with the complexes con-
tainingKv1.3 channels (Fig. 6D) could provide an indirect argu-
ment supporting a role for serine residues in proliferation
signaling pathways, as ERKs substrates are phosphorylated in
Ser/Thr residues.
Overall, our data suggest that the molecular nature of the
voltage sensor that activates the signaling pathway facilitating
proliferation is relevant. The effect on proliferation is lost when
the channel is not able to sense the voltage and is increased
when the voltage-dependent transitions are facilitated. How-
ever, the changes in EM are not sufficient to promote prolifera-
tion, as illustrated by the overexpression of Kv1.5 channels,
which promotes a similar hyperpolarization (13) but in the
absence of the specific domains is not able to induce prolifera-
tion (in fact it has the opposite effect). These data open inter-
esting questions to identify the signaling pathways by which
Kv1.3 channels (and not Kv1.5 channels) potentiate cell prolif-
eration in several native systems. The contribution of Kv1.3
channels to cell proliferation in these systems can be related to
their role as effectors of the cell cycle machinery, participating
in the regulation of signaling cascades via protein-protein inter-
actions. The identification of these signaling cascades and of
the molecules involved in this non-canonical function of Kv
channels will provide a better understanding of these pro-
cesses and will pave the way for the development of new,
more specific therapies based on ion channels for controlling
cell proliferation.
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